ClinicalTrials.Veeva

Menu

Effects of Transcutaneous Electrical Nerve Stimulation (TENS) to Improve the Cognitive Functions in Older Adults

T

The Hong Kong Polytechnic University

Status

Completed

Conditions

Mild Cognitive Impairment

Treatments

Device: Concha TENS
Device: T1 TENS
Device: Control

Study type

Interventional

Funder types

Other

Identifiers

NCT05408689
2022_TVNS

Details and patient eligibility

About

Recent evidence has shown that transcutaneous electrical nerve stimulation (TENS) was effective in improving the cognitive function in healthy adult and people with dementia. However, lacking of evidence investigated the effect of TENS in improving the cognitive function and reversing the occurrence of dementia during the period of mild cognitive impairment (MCI), which is the crucial period to prevent the significant loss of cognition function. Therefore, the main objective of this study is to investigate the optimal TENS treatment protocol in improving the cognitive function in older adults with MCI.

Full description

This study aims to investigate the effectiveness of 3 intervention protocols (1) In the T1 TENS group, the subject will receive TENS on T1 spine. (2) In the vagus nerve TENS group, the subject will receive TENS on the concha of left outer ear. (3) In the sham stimulation group, the subject will receive sham stimulation on the T1 spine, in improving the cognitive function in older adults with MCI.

Enrollment

90 patients

Sex

All

Ages

55 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Should fulfil the diagnosis criteria of MCI (Albert et al., 2011):

  1. Concern regarding a change in cognition
  2. Impairment in one or more cognitive domains
  3. Preservation of independence in functional abilities
  4. no signs of dementia were to be present and confirmed by the medical staff and medical records.

Exclusion criteria

  1. If their medical records reported a history of either psychiatric disorder, alcoholism, cerebral trauma, cerebrovascular disease, hydrocephalus, neoplasm, epilepsy, disturbances of consciousness, insulin-dependent diabetes mellitus or focal brain disorders;
  2. Having active implants, such as cochlear implants, pacemaker;
  3. Having wounds and diseased skin on the electrode position.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

90 participants in 3 patient groups, including a placebo group

T1 TENS
Experimental group
Description:
In this study, participants will be treated 30 min per day, 3 days per week, for 10 consecutive weeks
Treatment:
Device: T1 TENS
Concha TENS
Experimental group
Description:
In this study, participants will be treated 30 min per day, 3 days per week, for 10 consecutive weeks
Treatment:
Device: Concha TENS
Control
Placebo Comparator group
Description:
In this study, participants will be treated 30 min per day, 3 days per week, for 10 consecutive weeks
Treatment:
Device: Control

Trial contacts and locations

1

Loading...

Central trial contact

Shamay NG, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems